27th Annual United States Conference on HIV/AIDS (USCHA)

第 27 届美国艾滋病毒/艾滋病年会 (USSHA)

基本信息

  • 批准号:
    10760611
  • 负责人:
  • 金额:
    $ 18.68万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-08-10 至 2023-12-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT In 1996, a group of national HIV organizations came together to create the United States Conference on AIDS (USCA) – then known as the National Skills Building Conference. Led by NMAC, this coalition understood the value of bringing together the diverse communities impacted by the disease to be educated on the latest science, build support and bring hope to people facing an epidemic. In 2020, this was renamed as the United States Conference on HIV/AIDS (USCHA). As one of the largest domestic HIV/AIDS conferences with a community focus, USCHA receives an average attendance of 3,200 people each year. Attendees include case managers, representatives from local, state and federal government, capacity building providers, researchers, representatives from national AIDS services organizations, pharmaceutical representatives, peer navigators and people living with HIV. Skills building takes place in the form of over 140 2-hour workshops, 30 poster sessions and 4 plenary sessions. USCHA is held every other year in Washington, DC to ensure the maximum possible participation by federal representatives. The 2023 USCHA will be held in Washington, DC at the Marriott Marquis Hotel from September 6 - 9. USCHA focuses on a range of HIV/AIDS issues. Content is developed and organized for the conference through various channels including institutes, conference tracks and through the submission of abstracts. The conference has moved from a program developed mainly through abstract submissions to include curated content identified by the conference planning committee and direct outreach to subject matter experts. Several federal agencies, including the Centers for Disease Control and Prevention, Health Resources and Services Administration, Indian Health Service, National Institutes of Health, Substance Abuse and Mental Health Services Administration and the HHS Office of Infectious Disease Policy, have partnered with USCHA to conduct workshops on prevention, care and treatment, hepatitis, PrEP, viral suppression and stigma in minority communities. Other workshops are filled through a call for abstract submissions which are reviewed by committees of experts in their respective fields. The conference is organized into Conference Tracks that feature workshops in the areas of biomedical HIV prevention, gay men, leadership, people living with HIV, stigma and public policy. Each year, tracks are reviewed and changed as needed to reflect current issues and OAR HIV/AIDS Priorities. NMAC previously partnered with the DC CFAR to host a series of workshops on HIV treatment and cure research. The UNC CFAR looks forward to continuing this partnership. Conference support from the NIH R13 grant will be used to support this collaboration, provide technological support for 15-18 virtual workshops and fund conference scholarships for people living with HIV over 50, cis and trans women, emerging youth leaders and people of color. As collaborators, the UNC CFAR leadership and HIV investigators will contribute their guidance and expertise as NMAC develops the 2023 agenda.
项目总结/摘要 1996年,一群国家艾滋病毒组织聚集在一起,创建了美国艾滋病会议 (USCA)-当时被称为国家技能建设会议。在NMAC的领导下,这个联盟明白, 将受疾病影响的不同社区聚集在一起, 科学,建立支持,给面临疫情的人们带来希望。在2020年,这被重新命名为联合国 国家艾滋病毒/艾滋病问题会议。作为国内最大的艾滋病毒/艾滋病会议之一, 人道协调厅以社区为重点,每年平均接待3,200人。与会者包括案件 地方、州和联邦政府的管理人员、代表、能力建设提供者、研究人员, 来自国家艾滋病服务组织的代表、医药代表、同行领航员 和艾滋病病毒携带者。技能建设以140多个2小时的讲习班,30张海报的形式进行 会议和4次全体会议。UCHA每隔一年在华盛顿举行一次,以确保最大限度地 联邦代表的可能参与。2023年UCHA将在美国首都华盛顿举行 Marriott Marquis酒店,9月6日至9日。 人道协调厅侧重于一系列艾滋病毒/艾滋病问题。为会议编写和组织内容 通过各种渠道,包括研究所、会议轨道和通过提交摘要。的 会议已经从一个主要通过抽象提交来开发的项目, 会议规划委员会确定的内容和与专题专家的直接外联。几 联邦机构,包括疾病控制和预防中心、卫生资源和服务中心 行政部门、印度卫生署、国立卫生研究院、药物滥用和精神卫生 服务管理局和卫生与公众服务部传染病政策办公室与人道协调厅合作, 举办关于少数群体预防、护理和治疗、肝炎、PrEP、病毒抑制和污名化的讲习班 社区.其他研讨会通过呼吁提交摘要来填补,这些摘要由 各领域的专家委员会。会议被组织成会议轨道, 在生物医学艾滋病毒预防、男同性恋、领导力、艾滋病毒感染者、 耻辱和公共政策。每年,都会根据需要对曲目进行审查和更改,以反映当前的问题, OAR艾滋病毒/艾滋病优先事项国家艾滋病毒/艾滋病咨询中心以前曾与哥伦比亚特区艾滋病毒和艾滋病论坛合作举办了一系列关于艾滋病毒的讲习班 治疗和治愈研究。难民专员办事处期待着继续这种伙伴关系。会议支助 NIH R13赠款将用于支持这项合作,为15 - 18人提供技术支持。 为50岁以上的艾滋病毒感染者、顺性和变性妇女举办虚拟讲习班并提供会议奖学金, 青年领袖和有色人种。作为合作者,非洲艾滋病毒/艾滋病联合会领导层和艾滋病毒/艾滋病联合会 调查人员将在NMAC制定2023年议程时提供指导和专业知识。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ronald I Swanstrom其他文献

Ronald I Swanstrom的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ronald I Swanstrom', 18)}}的其他基金

25th Annual United States Conference on HIV/AIDS (USCHA)
第 25 届美国艾滋病毒/艾滋病年会 (USSHA)
  • 批准号:
    10323910
  • 财政年份:
    2021
  • 资助金额:
    $ 18.68万
  • 项目类别:
Formation of the HIV-1 Latent Reservoir
HIV-1 潜伏库的形成
  • 批准号:
    10552552
  • 财政年份:
    2020
  • 资助金额:
    $ 18.68万
  • 项目类别:
Formation of the HIV-1 Latent Reservoir
HIV-1 潜伏库的形成
  • 批准号:
    10013718
  • 财政年份:
    2020
  • 资助金额:
    $ 18.68万
  • 项目类别:
Formation of the HIV-1 Latent Reservoir
HIV-1 潜伏库的形成
  • 批准号:
    10343734
  • 财政年份:
    2020
  • 资助金额:
    $ 18.68万
  • 项目类别:
HIV Evolution Defines Virus-Host/Drug Interactions In Viremic and Aviremic People
HIV进化定义了病毒血症和无病毒血症人群中病毒-宿主/药物的相互作用
  • 批准号:
    10180893
  • 财政年份:
    2018
  • 资助金额:
    $ 18.68万
  • 项目类别:
HIV Evolution Defines Virus-Host/Drug Interactions In Viremic and Aviremic People
HIV进化定义了病毒血症和无病毒血症人群中病毒-宿主/药物的相互作用
  • 批准号:
    10412103
  • 财政年份:
    2018
  • 资助金额:
    $ 18.68万
  • 项目类别:
Identifying A New Class of HIV Maturation Inhibitors
鉴定一类新的 HIV 成熟抑制剂
  • 批准号:
    9529507
  • 财政年份:
    2017
  • 资助金额:
    $ 18.68万
  • 项目类别:
Biological Properties of HIV-1 V3 Evolutionary Variants
HIV-1 V3 进化变异体的生物学特性
  • 批准号:
    9321715
  • 财政年份:
    2016
  • 资助金额:
    $ 18.68万
  • 项目类别:
Timing of establishment of the HIV latent reservoir in subtype C infected women
C 亚型感染女性中 HIV 潜伏病毒库建立的时机
  • 批准号:
    8838888
  • 财政年份:
    2015
  • 资助金额:
    $ 18.68万
  • 项目类别:
Timing of establishment of the HIV latent reservoir in subtype C infected women
C 亚型感染女性中 HIV 潜伏病毒库建立的时机
  • 批准号:
    8997446
  • 财政年份:
    2015
  • 资助金额:
    $ 18.68万
  • 项目类别:

相似海外基金

RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    10219039
  • 财政年份:
    2020
  • 资助金额:
    $ 18.68万
  • 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9981476
  • 财政年份:
    2019
  • 资助金额:
    $ 18.68万
  • 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9364184
  • 财政年份:
    2016
  • 资助金额:
    $ 18.68万
  • 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
  • 批准号:
    236932
  • 财政年份:
    2011
  • 资助金额:
    $ 18.68万
  • 项目类别:
    Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554155
  • 财政年份:
    1991
  • 资助金额:
    $ 18.68万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6766860
  • 财政年份:
    1991
  • 资助金额:
    $ 18.68万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554156
  • 财政年份:
    1991
  • 资助金额:
    $ 18.68万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6256640
  • 财政年份:
    1991
  • 资助金额:
    $ 18.68万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
  • 批准号:
    2063342
  • 财政年份:
    1991
  • 资助金额:
    $ 18.68万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6091256
  • 财政年份:
    1991
  • 资助金额:
    $ 18.68万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了